Application no. and date | 02802898.3 (espacenet) (Federated) (European Patent Register), 20021108 | Patent/reg. no. and date | DK/EP 1476185, 20130731 | Publication date | 20041117 | Priority no. and date | US 348980 P, 20011109 | EP pub. no. and date |
EP 1476185 20041117 | Effective date | | Applicant/owner | Pfizer Products Inc., Eastern Point Road
Groton, CT 06340, US, Amgen Fremont Inc., One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US | Applicant ref. no. | NGC/GP/147531 | Inventor | BEDIAN, Vahe, 3 Frog Hollow Road
East Lyme, CT 06333, US, GLADUE, Ronald, P., 83 Rowley Drive
Stonington, CT 06378, US, CORVALAN, Jose, 125 Williams lane
Foster City, CA 94404, US, FENG, Xiao, 135 Red Cedar Lane
Union City, CA 94587, US, JIA, Xiao-Chi, 22 Murray Court
San Mateo, CA 94403, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 39/395 (2006.01) , C07K 16/28 (2006.01) , C12N 15/00 (2006.01) , C12N 15/11 (2006.01) , C12N 15/12 (2006.01) , C12N 15/63 (2006.01) , C12N 5/10 (2006.01) | Title | Antistoffer mod CD40 | Int. application no. | US2002036107 | Int. publication no. | WO2003040170 | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|